Search
Xininurad
go.drugbank.com/drugs/DB21564ExperimentalXininurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Xininurad is a urate transporter inhibitor.
Ansornitinib
go.drugbank.com/drugs/DB21577ExperimentalAnsornitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Ansornitinib is a tyrosine kinase inhibitor.
Garsorasib
go.drugbank.com/drugs/DB21581InvestigationalGarsorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Garsorasib is a Ras protein inhibitor. Garsorasib has a monoisotopic molecular weight of 598.26 Da.
Gumelutamide
go.drugbank.com/drugs/DB21615ExperimentalGumelutamide is a small molecule drug. The usage of the INN stem '-lutamide' in the name indicates that Gumelutamide is a non-steroid antiandrogen.
Frevecitinib
go.drugbank.com/drugs/DB21681InvestigationalFrevecitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Frevecitinib is a Janus kinase inhibitor.
Odentegravir
go.drugbank.com/drugs/DB21708ExperimentalOdentegravir is a small molecule drug. The usage of the INN stem '-tegravir' in the name indicates that Odentegravir is a HIV integrase inhibitor.
VTX-801
go.drugbank.com/drugs/DB17646InvestigationalIt is being investigated in Wilson Disease.[L45924] … VTX-801 is a replication-deficient recombinant adeno-associated viral vector (rAAV) consisting of an AAV liver tropic capsid containing a single-stranded DNA genome carrying a shortened version of the
Atamparib
go.drugbank.com/drugs/DB19028InvestigationalAtamparib is under investigation in clinical trial NCT05127590 (RBN-2397 in Combination With Pembrolizumab in Patients With SCCL).
Bifenthrin
go.drugbank.com/drugs/DB15056ExperimentalBifenthrin is under investigation in clinical trial NCT01560247 (Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry).
Sulopenem
go.drugbank.com/drugs/DB15284InvestigationalSulopenem is a penem antibacterial. It is marketed as the prodrug [sulopenem etzadroxil] in combination with [probenecid].[L51768]